期刊文献+

Prognosis of metastatic splenic hilum lymph node in patients with gastric cancer after total gastrectomy and splenectomy 被引量:27

Prognosis of metastatic splenic hilum lymph node in patients with gastric cancer after total gastrectomy and splenectomy
下载PDF
导出
摘要 AIM:To clarify the significance of combined resection of the spleen to dissect the No.10 lymph node(LN). METHODS:We studied 191 patients who had undergone total gastrectomy with splenectomy,excluding non-curative cases,resection of multiple gastric cancer, and those with remnant stomach cancer.Various clinico-pathological factors were evaluated for any independent contributions to No.10 LN metastasis,usingχ 2 test. Significant factors were extracted for further analysis, carried out using a logistic regression method.Furthermore,lymph node metastasis was evaluated for any independent contribution to No.10 LN metastasis,using the same methods.The cumulative survival rate was calculated using the Kaplan-Meier method.The significance of any difference between the survival curves was determined using the Cox-Mantel test,and any difference was considered significant at the 5%level. RESULTS:From the variables considered to be potentially associated with No.10 LN metastasis,age, depth,invasion of lymph vessel,N factor,the numberof lymph node metastasis,Stage,the number of sites, and location were found to differ significantly between those with metastasis(the Positive Group)and those without(the Negative Group).A logistic regression analysis showed that the localization and Stage were significant parameters for No.10 LN metastasis.There was no case located on the lesser curvature in the Posi-tive Group.The numbers of No.2,No.3,No.4sa,No. 4sb,No.4d,No.7,and No.11 LN metastasis were each found to differ significantly between the Positive Group and the Negative Group.A logistic regression analysis showed that No.4sa,No.4sb,and No.11 LN metastasis were each a significant parameter for No.10 LN metastasis.There was no significant difference in survival curves between the Positive Group and the Negative Group. CONCLUSION:Splenectomy should be performed to dissect No.10 LN for cases which have No.4sa,No. 4sb or No.11 LN metastasis.However,in cases where the tumor is located on the lesser curvature,splenectomy can be omitted. AIM: To clarify the significance of combined resection of the spleen to dissect the No. 10 lymph node (LN).METHODS: We studied 191 patients who had undergone total gastrectomy with splenectomy, excluding non-curative cases, resection of multiple gastric cancer, and those with remnant stomach cancer. Various clinicopathological factors were evaluated for any independent contributions to No. 10 LN metastasis, using χ2 test. Significant factors were extracted for further analysis, carried out using a logistic regression method. Furthermore, lymph node metastasis was evaluated for any independent contribution to No. 10 LN metastasis, using the same methods. The cumulative survival rate was calculated using the Kaplan-Meier method. The significance of any difference between the survival curves was determined using the Cox-Mantel test, and any difference was considered significant at the 5% level.RESULTS: From the variables considered to be potentially associated with No. 10 LN metastasis, age, depth, invasion of lymph vessel, N factor, the number of lymph node metastasis, Stage, the number of sites, and location were found to differ significantly between those with metastasis (the Positive Group) and those without (the Negative Group). A logistic regression analysis showed that the localization and Stage were significant parameters for No. 10 LN metastasis. There was no case located on the lesser curvature in the Positive Group. The numbers of No. 2, No. 3, No. 4sa, No. 4sb, No. 4d, No. 7, and No. 11 LN metastasis were each found to differ significantly between the Positive Group and the Negative Group. A logistic regression analysis showed that No. 4sa, No. 4sb, and No. 11 LN metastasis were each a significant parameter for No. 10 LN metastasis. There was no significant difference in survival curves between the Positive Group and the Negative Group.CONCLUSION: Splenectomy should be performed to dissect No. 10 LN for cases which have No. 4sa, No. 4sb or No. 11 LN metastasis. However, in cases where the tumor is located on the lesser curvature, splenectomy can be omitted.
机构地区 Department ofSurgery
出处 《World Journal of Hepatology》 CAS 2010年第2期81-86,共6页 世界肝病学杂志(英文版)(电子版)
关键词 Gastric cancer LYMPH node metastasis Lymphadenectomy Splenectomy Total GASTRECTOMY Gastric cancer Lymph node metastasis Lymphadenectomy Splenectomy Total gastrectomy
  • 相关文献

参考文献17

  • 1Chew-Wun Wu MD,I-Shou Chang PhD,Su-shun Lo MD,Mao-Chin Hsieh MD,Jen-Hao Chen MD,Wing-Yiu Lui MD,Jacqueline Whang-Peng MD.Complications Following D3 Gastrectomy: Post Hoc Analysis of a Randomized Trial[J]. World Journal of Surgery . 2006 (1)
  • 2Jürgen Weitz MD, PhD,David P. Jaques MD, FACS,Murray Brennan MD, FACS,Martin Karpeh MD, FACS.Association of Splenectomy With Postoperative Complications in Patients With Proximal Gastric and Gastroesophageal Junction Cancer[J]. Annals of Surgical Oncology . 2004 (7)
  • 3Japanese Gastric Cancer Association.Japanese classification of gastric carcinoma. . 1999
  • 4Chikara K,Hiroshi S,Masato N,Hirotoshi A,Goro M,Hidetaka O.Indications for pancreaticosplenectomy in advanced gastric cancer. Hepato Gastroenterology . 2001
  • 5Okinaga K,Iinuma H,Kitamura Y,Yokohata T,Inaba T,Fukushima R.Effect of immunotherapy and spleen preservation on immunological function in patients with gastric cancer. Journal of Experimental and Clinical Cancer Research . 2006
  • 6Otsuji E,Yamaguchi T,Sawai K,Okamoto K,Takahashi T.Total gastrectomy with simultaneous pancreatico- splenectomy or splenectomy in patients with advanced gastric carcinoma. British Journal of Cancer . 1999
  • 7Kitamura K,Nishida S,Yamamoto K,Ichikawa D,Okamoto K,Taniguchi H,Yamaguchi T,Sawai K,Takahashi T.Lymph node metastasis in gastric cancer in the upper third of the stomach--surgical treatment on the basis of the anatomical distribution of positive node. Hepato Gastroenterology . 1998
  • 8Yamamoto M,Baba H,Kakeji Y,Endo K,Ikeda Y,Toh Y,Kohnoe S,Okamura T,Maehara Y.Postoperative morbidity/ mortality and survival rates after total gastrectomy,with splenectomy/pancreaticosplenectomy for patients with advanced gastric cancer. Hepato Gastroenterology . 2004
  • 9Csendes A,Burdiles P,Rojas J,et al.A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Journal of Surgery . 2002
  • 10D. Roukos,A. Schmidt-Mathiesen,A. Encke.Adenocarcinoma of the gastric antrum: does D2 total gastrectomy with splenectomy improve prognosis compared to D1 subtotal gastrectomy? A long-term survival analysis with emphasis on Lauren classification. Surgical Oncology . 1995

共引文献2

同被引文献260

引证文献27

二级引证文献481

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部